JP6684929B2 - 血管内圧力測定及び外部超音波撮像を使用して脈波伝播速度を決定するための関連するデバイス、システム、及び方法 - Google Patents
血管内圧力測定及び外部超音波撮像を使用して脈波伝播速度を決定するための関連するデバイス、システム、及び方法 Download PDFInfo
- Publication number
- JP6684929B2 JP6684929B2 JP2018560138A JP2018560138A JP6684929B2 JP 6684929 B2 JP6684929 B2 JP 6684929B2 JP 2018560138 A JP2018560138 A JP 2018560138A JP 2018560138 A JP2018560138 A JP 2018560138A JP 6684929 B2 JP6684929 B2 JP 6684929B2
- Authority
- JP
- Japan
- Prior art keywords
- blood vessel
- pressure
- processing system
- data
- velocity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims description 65
- 238000009530 blood pressure measurement Methods 0.000 title description 8
- 238000012285 ultrasound imaging Methods 0.000 title description 4
- 210000004204 blood vessel Anatomy 0.000 claims description 137
- 238000012545 processing Methods 0.000 claims description 135
- 238000003384 imaging method Methods 0.000 claims description 132
- 238000002604 ultrasonography Methods 0.000 claims description 59
- 239000012530 fluid Substances 0.000 claims description 55
- 230000008660 renal denervation Effects 0.000 claims description 35
- 210000002254 renal artery Anatomy 0.000 claims description 32
- 238000012544 monitoring process Methods 0.000 claims description 25
- 238000004891 communication Methods 0.000 claims description 19
- 230000008901 benefit Effects 0.000 claims description 13
- 230000008859 change Effects 0.000 claims description 13
- 230000000007 visual effect Effects 0.000 claims description 6
- 230000001225 therapeutic effect Effects 0.000 claims description 5
- 238000002560 therapeutic procedure Methods 0.000 claims description 5
- 230000001360 synchronised effect Effects 0.000 claims description 2
- 210000003734 kidney Anatomy 0.000 description 44
- 230000002889 sympathetic effect Effects 0.000 description 24
- 206010020772 Hypertension Diseases 0.000 description 21
- 210000002820 sympathetic nervous system Anatomy 0.000 description 21
- 210000005036 nerve Anatomy 0.000 description 17
- 230000000747 cardiac effect Effects 0.000 description 16
- 210000002216 heart Anatomy 0.000 description 16
- 210000004369 blood Anatomy 0.000 description 15
- 239000008280 blood Substances 0.000 description 15
- 230000036772 blood pressure Effects 0.000 description 15
- 239000000523 sample Substances 0.000 description 14
- 230000008035 nerve activity Effects 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 210000003484 anatomy Anatomy 0.000 description 10
- 206010047139 Vasoconstriction Diseases 0.000 description 9
- 230000004913 activation Effects 0.000 description 8
- 210000004556 brain Anatomy 0.000 description 8
- 208000020832 chronic kidney disease Diseases 0.000 description 8
- 102100028255 Renin Human genes 0.000 description 7
- 108090000783 Renin Proteins 0.000 description 7
- 238000010586 diagram Methods 0.000 description 7
- 239000011734 sodium Substances 0.000 description 7
- 230000025033 vasoconstriction Effects 0.000 description 7
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- 238000002592 echocardiography Methods 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 230000028327 secretion Effects 0.000 description 6
- 229910052708 sodium Inorganic materials 0.000 description 6
- 238000013517 stratification Methods 0.000 description 6
- 206010019280 Heart failures Diseases 0.000 description 5
- 210000000702 aorta abdominal Anatomy 0.000 description 5
- 230000002526 effect on cardiovascular system Effects 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 230000036454 renin-angiotensin system Effects 0.000 description 5
- 210000005166 vasculature Anatomy 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 206010007558 Cardiac failure chronic Diseases 0.000 description 4
- 206010041277 Sodium retention Diseases 0.000 description 4
- 230000004872 arterial blood pressure Effects 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 230000000903 blocking effect Effects 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 4
- 230000003054 hormonal effect Effects 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- 230000001631 hypertensive effect Effects 0.000 description 4
- 230000002093 peripheral effect Effects 0.000 description 4
- 208000015658 resistant hypertension Diseases 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 230000000638 stimulation Effects 0.000 description 4
- 230000008700 sympathetic activation Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 230000002792 vascular Effects 0.000 description 4
- 208000031481 Pathologic Constriction Diseases 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 230000029142 excretion Effects 0.000 description 3
- 230000013632 homeostatic process Effects 0.000 description 3
- 230000003907 kidney function Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 230000007383 nerve stimulation Effects 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000008327 renal blood flow Effects 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 230000036262 stenosis Effects 0.000 description 3
- 208000037804 stenosis Diseases 0.000 description 3
- 230000009885 systemic effect Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- 206010022489 Insulin Resistance Diseases 0.000 description 2
- 208000007177 Left Ventricular Hypertrophy Diseases 0.000 description 2
- 229920002614 Polyether block amide Polymers 0.000 description 2
- 206010063897 Renal ischaemia Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 238000010009 beating Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000002638 denervation Effects 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 210000000609 ganglia Anatomy 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000004126 nerve fiber Anatomy 0.000 description 2
- 230000004007 neuromodulation Effects 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- 235000021023 sodium intake Nutrition 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- 239000005541 ACE inhibitor Substances 0.000 description 1
- 206010003658 Atrial Fibrillation Diseases 0.000 description 1
- 208000004990 Cardiorenal syndrome Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000003417 Central Sleep Apnea Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 102100025283 Gap junction alpha-8 protein Human genes 0.000 description 1
- 208000029422 Hypernatremia Diseases 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010037211 Psychomotor hyperactivity Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 206010049418 Sudden Cardiac Death Diseases 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 230000007495 abnormal renal function Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 210000003403 autonomic nervous system Anatomy 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000011461 current therapy Methods 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 208000028208 end stage renal disease Diseases 0.000 description 1
- 201000000523 end stage renal failure Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000003090 exacerbative effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000008571 general function Effects 0.000 description 1
- 230000005182 global health Effects 0.000 description 1
- 210000004013 groin Anatomy 0.000 description 1
- 210000003709 heart valve Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000004705 lumbosacral region Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 239000000712 neurohormone Substances 0.000 description 1
- 229910001000 nickel titanium Inorganic materials 0.000 description 1
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000008816 organ damage Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- -1 polytetrafluoroethylene Polymers 0.000 description 1
- 230000012495 positive regulation of renal sodium excretion Effects 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 230000035485 pulse pressure Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 238000000718 qrs complex Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000002796 renal vein Anatomy 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 229910001285 shape-memory alloy Inorganic materials 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 210000002466 splanchnic nerve Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- CCEKAJIANROZEO-UHFFFAOYSA-N sulfluramid Chemical group CCNS(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F CCEKAJIANROZEO-UHFFFAOYSA-N 0.000 description 1
- 210000000331 sympathetic ganglia Anatomy 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000006442 vascular tone Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000001631 vena cava inferior Anatomy 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/026—Measuring blood flow
- A61B5/0285—Measuring or recording phase velocity of blood waves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/02007—Evaluating blood vessel condition, e.g. elasticity, compliance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/02108—Measuring pressure in heart or blood vessels from analysis of pulse wave characteristics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/0215—Measuring pressure in heart or blood vessels by means inserted into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/20—Measuring for diagnostic purposes; Identification of persons for measuring urological functions restricted to the evaluation of the urinary system
- A61B5/201—Assessing renal or kidney functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7239—Details of waveform analysis using differentiation including higher order derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient; User input means
- A61B5/742—Details of notification to user or communication with user or patient; User input means using visual displays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/04—Measuring blood pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/06—Measuring blood flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/08—Clinical applications
- A61B8/0891—Clinical applications for diagnosis of blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/48—Diagnostic techniques
- A61B8/485—Diagnostic techniques involving measuring strain or elastic properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/022—Measuring pressure in heart or blood vessels by applying pressure to close blood vessels, e.g. against the skin; Ophthalmodynamometers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4887—Locating particular structures in or on the body
- A61B5/489—Blood vessels
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Pathology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Physiology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Artificial Intelligence (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Psychiatry (AREA)
- Signal Processing (AREA)
- Urology & Nephrology (AREA)
- Evolutionary Computation (AREA)
- Fuzzy Systems (AREA)
- Mathematical Physics (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16170635.3 | 2016-05-20 | ||
| EP16170635 | 2016-05-20 | ||
| EP16176863 | 2016-06-29 | ||
| EP16176863.5 | 2016-06-29 | ||
| PCT/EP2017/062230 WO2017198871A1 (en) | 2016-05-20 | 2017-05-22 | Determining pulse wave velocity using intravascular pressure measurement and external ultrasound imaging, and associated devices, systems, and methods |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019518518A JP2019518518A (ja) | 2019-07-04 |
| JP2019518518A5 JP2019518518A5 (enExample) | 2019-11-14 |
| JP6684929B2 true JP6684929B2 (ja) | 2020-04-22 |
Family
ID=58873791
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018560138A Expired - Fee Related JP6684929B2 (ja) | 2016-05-20 | 2017-05-22 | 血管内圧力測定及び外部超音波撮像を使用して脈波伝播速度を決定するための関連するデバイス、システム、及び方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20190082978A1 (enExample) |
| EP (1) | EP3457928B1 (enExample) |
| JP (1) | JP6684929B2 (enExample) |
| CN (1) | CN109152541A (enExample) |
| WO (1) | WO2017198871A1 (enExample) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12465324B2 (en) | 2015-02-12 | 2025-11-11 | Foundry Innovation & Research 1, Ltd. | Patient fluid management systems and methods employing integrated fluid status sensing |
| JP6924701B2 (ja) | 2015-02-12 | 2021-08-25 | ファウンドリー イノベーション アンド リサーチ １，リミテッドＦｏｕｎｄｒｙ Ｉｎｎｏｖａｔｉｏｎ ＆ Ｒｅｓｅａｒｃｈ １，Ｌｔｄ． | 心不全を監視するための移植可能デバイスおよび関連方法 |
| US11039813B2 (en) | 2015-08-03 | 2021-06-22 | Foundry Innovation & Research 1, Ltd. | Devices and methods for measurement of Vena Cava dimensions, pressure and oxygen saturation |
| US11701018B2 (en) | 2016-08-11 | 2023-07-18 | Foundry Innovation & Research 1, Ltd. | Wireless resonant circuit and variable inductance vascular monitoring implants and anchoring structures therefore |
| US11206992B2 (en) | 2016-08-11 | 2021-12-28 | Foundry Innovation & Research 1, Ltd. | Wireless resonant circuit and variable inductance vascular monitoring implants and anchoring structures therefore |
| EP3496606A1 (en) | 2016-08-11 | 2019-06-19 | Foundry Innovation & Research 1, Ltd. | Systems and methods for patient fluid management |
| JP7241405B2 (ja) | 2016-11-29 | 2023-03-17 | ファウンドリー イノベーション アンド リサーチ １，リミテッド | 患者の血管及び体液状態をモニタリングするための無線共振回路ならびに可変インダクタンス血管インプラント、ならびにそれを利用するシステム及び方法 |
| DE102016123846A1 (de) * | 2016-12-08 | 2018-06-14 | Visus Health It Gmbh | Detektorband für Röntgenfilm |
| WO2018178327A1 (en) * | 2017-03-31 | 2018-10-04 | Koninklijke Philips N.V. | Intravascular flow and pressure measurements |
| US11779238B2 (en) | 2017-05-31 | 2023-10-10 | Foundry Innovation & Research 1, Ltd. | Implantable sensors for vascular monitoring |
| EP3629937A1 (en) | 2017-05-31 | 2020-04-08 | Foundry Innovation & Research 1, Ltd. | Implantable ultrasonic vascular sensor |
| EP3613350A1 (en) | 2018-08-21 | 2020-02-26 | Koninklijke Philips N.V. | Systems and method for performing pulse wave velocity measurements |
| EP3714780A1 (en) | 2019-03-28 | 2020-09-30 | Koninklijke Philips N.V. | Pulse wave velocity measurement system |
| JP7649237B2 (ja) | 2018-10-26 | 2025-03-19 | コーニンクレッカ フィリップス エヌ ヴェ | 脈波伝播速度測定システム |
| EP3643222A1 (en) * | 2018-10-26 | 2020-04-29 | Koninklijke Philips N.V. | Device and system for assessing reliability of vessel physiology related measurement |
| US12020791B2 (en) | 2018-10-26 | 2024-06-25 | Koninklijke Philips N.V. | Determination of a treatment response index |
| WO2020210490A1 (en) * | 2019-04-12 | 2020-10-15 | Ulink Labs, Inc. | Systems, devices, and methods for wireless monitoring |
| USD926199S1 (en) | 2019-05-17 | 2021-07-27 | Opsens, Inc. | Display screen or portion thereof with graphical user interface |
| CN114072064B (zh) * | 2019-07-11 | 2024-08-16 | 深圳迈瑞生物医疗电子股份有限公司 | 一种参数的检测方法以及参数检测系统 |
| CN112932537B (zh) * | 2019-12-10 | 2025-11-04 | 深圳迈瑞生物医疗电子股份有限公司 | 一种超声成像设备、脉搏波成像方法 |
| CN114072065B (zh) * | 2019-12-10 | 2025-04-08 | 深圳迈瑞生物医疗电子股份有限公司 | 一种超声成像设备和脉搏波成像方法 |
| WO2021236756A1 (en) * | 2020-05-19 | 2021-11-25 | Coravie Medical, Inc. | Injectable hemodynamic monitoring devices, systems and methods |
| CN114494100A (zh) * | 2020-10-26 | 2022-05-13 | 无锡祥生医疗科技股份有限公司 | 脉搏波速度的测量方法及超声设备 |
| WO2022141247A1 (zh) * | 2020-12-30 | 2022-07-07 | 深圳迈瑞生物医疗电子股份有限公司 | 超声成像设备和弹性参数的显示方法 |
| CN115337096A (zh) * | 2021-05-13 | 2022-11-15 | 苏州润迈德医疗科技有限公司 | 用于内脏动脉去交感神经的消融方法、系统及存储介质 |
| CN117882321A (zh) | 2021-06-29 | 2024-04-12 | 优林克实验室公司 | 用于在异质介质中建立无线链路的系统、装置和方法 |
| CN113456942B (zh) * | 2021-08-16 | 2022-09-06 | 瑞安市人民医院 | 具有分段调节功能的icu用智能输液装置 |
| US20230270407A1 (en) * | 2022-02-26 | 2023-08-31 | Xenter, Inc. | Medical devices, systems, and methods incorporating the same |
| EP4561673A1 (en) | 2022-07-29 | 2025-06-04 | Foundry Innovation & Research 1, Ltd. | Multistranded conductors adapted to dynamic in vivo environments |
| CN121001656A (zh) * | 2023-01-10 | 2025-11-21 | 贝克顿·迪金森公司 | 用于监测自身调节的系统和方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1991019451A1 (fr) * | 1990-06-19 | 1991-12-26 | Mitsuei Tomita | Dispositif de mesure de la vitesse et du volume du debit sanguin dans l'aorte |
| JP3857788B2 (ja) * | 1997-09-01 | 2006-12-13 | テルモ株式会社 | 循環器情報計測システム |
| WO2000055579A2 (en) * | 1999-03-16 | 2000-09-21 | Florence Medical Ltd. | A system and method for detection and characterization of stenosis, blood vessels flow and vessel walls properties using vessel geometrical measurements |
| JP3668687B2 (ja) * | 2001-01-30 | 2005-07-06 | アロカ株式会社 | 脈波伝播速度計測装置及び超音波診断装置 |
| WO2003047418A2 (en) * | 2001-11-29 | 2003-06-12 | University Of Medicine And Dentistry Of New Jersey | A modified esophageal doppler monitor |
| US7559894B2 (en) | 2003-09-18 | 2009-07-14 | New Paradigm Concepts, LLC | Multiparameter whole blood monitor and method |
| US7672706B2 (en) * | 2004-08-23 | 2010-03-02 | Boston Scientific Scimed, Inc. | Systems and methods for measuring pulse wave velocity with an intravascular device |
| CN101677810B (zh) * | 2007-06-04 | 2012-04-04 | 松下电器产业株式会社 | 超声波诊断装置 |
| JP5356507B2 (ja) * | 2009-04-24 | 2013-12-04 | 株式会社日立メディコ | 超音波撮像装置 |
| WO2011138698A1 (en) | 2010-05-03 | 2011-11-10 | Koninklijke Philips Electronics N.V. | Ultrasonic tracking of ultrasound transducer(s) aboard an interventional tool |
| US11357447B2 (en) * | 2012-05-31 | 2022-06-14 | Sonivie Ltd. | Method and/or apparatus for measuring renal denervation effectiveness |
| JP2016027835A (ja) * | 2012-12-11 | 2016-02-25 | 日立アロカメディカル株式会社 | 超音波撮像装置及び方法 |
| JP6466435B2 (ja) * | 2013-07-19 | 2019-02-06 | ボルケーノ コーポレイション | 導管を評価するためのシステム |
-
2017
- 2017-05-22 EP EP17726891.9A patent/EP3457928B1/en active Active
- 2017-05-22 WO PCT/EP2017/062230 patent/WO2017198871A1/en not_active Ceased
- 2017-05-22 CN CN201780031122.9A patent/CN109152541A/zh active Pending
- 2017-05-22 JP JP2018560138A patent/JP6684929B2/ja not_active Expired - Fee Related
-
2018
- 2018-11-19 US US16/194,872 patent/US20190082978A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017198871A1 (en) | 2017-11-23 |
| JP2019518518A (ja) | 2019-07-04 |
| EP3457928A1 (en) | 2019-03-27 |
| CN109152541A (zh) | 2019-01-04 |
| EP3457928B1 (en) | 2019-11-20 |
| US20190082978A1 (en) | 2019-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6684929B2 (ja) | 血管内圧力測定及び外部超音波撮像を使用して脈波伝播速度を決定するための関連するデバイス、システム、及び方法 | |
| JP7612816B2 (ja) | 管腔内超音波イメージングのための速度決定、並びに関連するデバイス、システム、及び方法 | |
| US20190175035A1 (en) | Devices and methods for determining pulse wave velocity based on changes in vessel diameter | |
| JP7493524B2 (ja) | 管腔内超音波イメージングのためのグラフィカル長手方向表示、並びに、関連するデバイス、システム、及び方法 | |
| US20190090856A1 (en) | Devices and methods for stratification of patients for renal denervation based on intravascular pressure and cross-sectional lumen measurements | |
| US20190290139A1 (en) | Apparatus and methods for determining pulse wave velocity using multiple pressure sensors | |
| JP2024161427A (ja) | 管腔内イメージングシステム、脈管内イメージングシステム、及びコンピュータプログラム | |
| JP4602972B2 (ja) | 超音波診断装置および超音波診断装置の制御方法 | |
| US9199082B1 (en) | Devices and methods for improved placement of implantable medical devices | |
| JP2019521730A (ja) | 血管内圧及び壁厚の測定値に基づいて腎除神経術のために患者の階層化を行うデバイス及び方法 | |
| JPWO2009013871A1 (ja) | 超音波診断装置 | |
| CN118613207A (zh) | 使用血管内数据与管腔外图像之间的共配准的脉搏波速度确定以及相关联的系统、设备和方法 | |
| EP3809976A1 (en) | System and method for determining pulse wave velocity of vessels | |
| US20250040880A1 (en) | Identifying suitable candidates for denervation therapy | |
| EP3263018A1 (en) | Devices and methods for stratification of patients for renal denervation based on intravascular pressure and wall thickness measurements | |
| WO2025190824A1 (en) | Renal nerve bundle co-registration with x-ray image for renal denervation treatment guidance | |
| WO2024110313A1 (en) | Method to quantify autonomic nervous system activity and to identify potential responders to autonomic modulation therapy | |
| JP2025020050A (ja) | 解剖学的マップをシェービングするための方法及びシステム |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20191002 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20191002 |
|
| A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20191002 |
|
| A975 | Report on accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A971005 Effective date: 20191023 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20191105 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200128 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20200303 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20200330 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6684929 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| LAPS | Cancellation because of no payment of annual fees |